Variant-derived SARS-CoV-2 spike protein does not directly cause platelet activation or hypercoagulability

Thrombosis has been associated with severity and mortality in COVID-19. SARS-CoV-2 infects the host via its spike protein. However, direct effects of spike proteins from SARS-CoV-2 variants on platelet activity and coagulability have not been examined. An ethically approved ex vivo study was perform...

Descripción completa

Detalles Bibliográficos
Autores principales: Kusudo, Eriko, Murata, Yutaka, Kawamoto, Shuji, Egi, Moritoki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198021/
https://www.ncbi.nlm.nih.gov/pubmed/37208552
http://dx.doi.org/10.1007/s10238-023-01091-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198021/
https://www.ncbi.nlm.nih.gov/pubmed/37208552
http://dx.doi.org/10.1007/s10238-023-01091-4

Ejemplares similares